AU4595985A - Creation of Inventions and Patents with Artificial Intelligence

AU4595985A – Cancer treatment
– Google Patents

AU4595985A – Cancer treatment
– Google Patents
Cancer treatment

Info

Publication number
AU4595985A

AU4595985A
AU45959/85A
AU4595985A
AU4595985A
AU 4595985 A
AU4595985 A
AU 4595985A
AU 45959/85 A
AU45959/85 A
AU 45959/85A
AU 4595985 A
AU4595985 A
AU 4595985A
AU 4595985 A
AU4595985 A
AU 4595985A
Authority
AU
Australia
Prior art keywords
cancer treatment
cancer
treatment
Prior art date
1984-08-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Application number
AU45959/85A
Inventor
Jakobus Booyens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sentrachem Ltd

Original Assignee
Sentrachem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1984-08-10
Filing date
1985-08-09
Publication date
1986-02-13

1985-08-09
Application filed by Sentrachem Ltd
filed
Critical
Sentrachem Ltd

1986-02-13
Publication of AU4595985A
publication
Critical
patent/AU4595985A/en

Status
Abandoned
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids

A61K31/19—Carboxylic acids, e.g. valproic acid

A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P35/00—Antineoplastic agents

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

AU45959/85A
1984-08-10
1985-08-09
Cancer treatment

Abandoned

AU4595985A
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

ZA845267

1984-08-10

ZA84/5267

1984-08-10

Publications (1)

Publication Number
Publication Date

AU4595985A
true

AU4595985A
(en)

1986-02-13

Family
ID=25577398
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU45959/85A
Abandoned

AU4595985A
(en)

1984-08-10
1985-08-09
Cancer treatment

Country Status (4)

Country
Link

EP
(1)

EP0175468A3
(en)

JP
(1)

JPS6183122A
(en)

AU
(1)

AU4595985A
(en)

IL
(1)

IL76071A0
(en)

Cited By (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU607509B2
(en)

1987-06-18
1991-03-07
Block Drug Company Inc., The
Treatment of periodontal disease

AU608571B2
(en)

1987-03-09
1991-04-11
Efamol Holdings Plc
Composition and method for treatment of peptic ulcers

AU643201B2
(en)

1989-03-20
1993-11-11
Scarista Limited
Use of eicosapentaenoic acid for the treatment of cachexia

Families Citing this family (24)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

JPH0686377B2
(en)

1985-09-30
1994-11-02
日清製粉株式会社

Cancer metastasis inhibitor

SE8604117D0
(en)

1986-09-29
1986-09-29
Kabivitrum Ab

COMPOSITION

AU601238B2
(en)

1986-11-13
1990-09-06
Efamol Holdings Plc
A method of treatment of pregnancy induced hypertension

US5034415A
(en)

1987-08-07
1991-07-23
Century Laboratories, Inc.
Treatment of diabetes mellitus

GB8819110D0
(en)

1988-08-11
1988-09-14
Norsk Hydro As
Antihypertensive drug & method for production

DE3901048A1
(en)

1989-01-14
1990-07-19
Chimicasa Gmbh

ANTIKACHECTIKUM

US5457130A
(en)

1989-03-20
1995-10-10
Cancer Research Campaign Technology Limited
Eicosapentaenoic acid used to treat cachexia

US5190978A
(en)

1989-09-29
1993-03-02
Dai-Ichi Kogyo Seiyaku Co. Ltd.
Carcinostatic compositions and methods

US5336792A
(en)

1990-03-12
1994-08-09
Einar Sola
Process for enrichment of fat with regard to polyunsaturated fatty acids and phospholipids, and application of such enriched fat

US5436269A
(en)

1991-11-14
1995-07-25
Sagami Chemical Research Center
Method for treating hepatitis

DE4304394A1
(en)

1993-02-13
1993-09-02
Fresenius Ag
Prepn. for nourishment of oncological patients – comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins

AU711482B2
(en)

1994-06-28
1999-10-14
Scotia Holdings Plc
Compositions for treatment of diabetic complications

EP0711503A3
(en)

1994-11-14
1997-11-26
Scotia Holdings Plc
Milk fortified with GLA and/or DGLA

DE19629433A1
(en)

1996-07-22
1998-01-29
Hoechst Ag

Preparation containing omega-3 fatty acids from microorganisms as a prophylactic or therapeutic agent against parasitic diseases in animals

GB9617847D0
(en)

1996-08-27
1996-10-09
Scotia Holdings Plc
Fatty acid treatment

SE0202188D0
(en)

2002-07-11
2002-07-11
Pronova Biocare As

A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product

EP2295529B2
(en)

2002-07-11
2022-05-18
Basf As
Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use

CA2692309C
(en)

2007-06-26
2016-08-16
N.V. Nutricia
Improving memory in subjects with mini-mental state examination of 24-26

WO2009002145A1
(en)

2007-06-26
2008-12-31
N.V. Nutricia
Lipid composition for improving function of brain functioning

WO2009002148A1
(en)

2007-06-27
2008-12-31
N.V. Nutricia
Food composition for prodromal dementia patients

WO2009002146A1
(en)

2007-06-26
2008-12-31
N.V. Nutricia
Supporting activities of daily living

CN101951923B
(en)

2007-12-20
2013-10-30
N.V.努特里奇亚
Liquid nucleotides/nucleosides-containing product

US8802680B2
(en)

2011-06-29
2014-08-12
The Penn State Research Foundation
Compositions, methods and kits for treating leukemia

US9877944B2
(en)

2013-04-22
2018-01-30
Smartfish As
Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

EP0004770B1
(en)

1978-04-11
1984-06-13
Efamol Limited
Pharmaceutical and dietary composition comprising gamma-linolenic acids

GB2134782B
(en)

1982-09-22
1987-03-04
Sentrachem Ltd
Anti-cancer compositions containing higher fatty acids

GB8302708D0
(en)

1983-02-01
1983-03-02
Efamol Ltd
Pharmaceutical and dietary composition

1985

1985-08-09
AU
AU45959/85A
patent/AU4595985A/en
not_active
Abandoned

1985-08-09
EP
EP85305660A
patent/EP0175468A3/en
not_active
Withdrawn

1985-08-10
JP
JP60176794A
patent/JPS6183122A/en
active
Pending

1985-08-11
IL
IL76071A
patent/IL76071A0/en
unknown

Cited By (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU608571B2
(en)

1987-03-09
1991-04-11
Efamol Holdings Plc
Composition and method for treatment of peptic ulcers

AU607509B2
(en)

1987-06-18
1991-03-07
Block Drug Company Inc., The
Treatment of periodontal disease

AU643201B2
(en)

1989-03-20
1993-11-11
Scarista Limited
Use of eicosapentaenoic acid for the treatment of cachexia

Also Published As

Publication number
Publication date

EP0175468A3
(en)

1987-07-22

JPS6183122A
(en)

1986-04-26

EP0175468A2
(en)

1986-03-26

IL76071A0
(en)

1985-12-31

Contact information